RxDoctor Payments Data

Daniel Cosgrove

Public Health & General Preventive Medicine · Indian Wells, CANPI 1235257429

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $57,809 of the $61,284 with a category attached, or 94.3%. AbbVie accounts for 94.8% of it on its own, with 24 other manufacturers making up the rest. Among public health & general preventive medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$61,284in general payments, 2019–2025

Across 153 payments — averaging $400.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$58K
  • Amgen$960
  • Illumina, Inc.$805
  • Novartis$176
  • Conformis, Inc.$158
  • Novo Nordisk$133
  • plus $983 from 19 others

What the payments were for

  • Speaking & faculty fees$57,80994%
  • Food & beverage$3,1165%
  • Education$570%
  • Gifts$2910%
  • Entertainment$130%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,284 in reported general payments places this provider in the 95th percentile of 109 public health & general preventive medicine providers in California.

See all public health & general preventive medicine providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept11$80,770
Repatha SureclickEvolocumab87$66,522
GenotropinSomatropin25$64,474
EliquisApixaban27$34,669
OzempicSemaglutide25$29,475
Praluent PenAlirocumab19$12,346
Buprenorphine12$5,325
Testosterone39$2,686
Estradiol (Twice Weekly)Estradiol27$2,026
Levothyroxine Sodium32$1,217
Valsartan34$1,021
Zolpidem Tartrate56$1,000
Eszopiclone16$995
ProgesteroneProgesterone, Micronized41$947
Tramadol Hcl ErTramadol Hcl12$916

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerGenotropin, Eliquis$31$99,14352 claims
Novo NordiskOzempic$133$29,47525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 109 public health & general preventive medicine providers in California.

Other public health & general preventive medicine in Indian Wells

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →